SCHEMBL14927045

SCHEMBL14927045

COc1cc(-c2cc3cc(C)c(C)cc3c3nccn23)cc(-c2cc(-c3ccccc3)cc(-c3ccccc3)c2)c1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTAFR P25105 2/20 0.49
▸ FYN P06241 1/20 0.40
▸ PAX8 Q06710 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ PDE5A O76074 1/20 0.37
▸ PDE6A P16499 1/20 0.37
▸ PDE1B Q01064 1/20 0.37
▸ PDE3A Q14432 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ CTDSP1 Q9GZU7 1/20 0.34
▸ ACHE P22303 1/20 0.34
▸ SYK P43405 1/20 0.34
▸ BRD4 O60885 2/20 0.34
▸ GLA P06280 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12070662 0.92 PTAFR (0.51) PTAFRFYNPAX8ALDH1A1KDM4E
SCHEMBL14926992 0.87 PTAFR (0.51) PTAFRFYNPAX8ALDH1A1KDM4E
SCHEMBL14906858 0.76 FYN (0.43) PTAFRFYNPAX8ALDH1A1KDM4E
SCHEMBL14927043 0.74 FYN (0.42) FYNALDH1A1KDM4EMAPTHPGD
SCHEMBL14903972 0.72 PTAFR (0.40) PTAFRFYNPAX8ALDH1A1KDM4E
SCHEMBL14927044 0.71 KMT2A (0.40) FYNMAPTSMN1; SMN2LMNAMEN1
SCHEMBL14927042 0.69 FYN (0.35) FYNALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL14930622 0.65 CTDSP1 (0.36) FYNPAX8ALDH1A1KDM4EHPGD
SCHEMBL12075016 0.65 PDGFRB (0.73) FYNALDH1A1MAPTSMN1; SMN2GLA
SCHEMBL12072009 0.65 CTDSP1 (0.46) FYNALDH1A1KDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8933096-B2 Antimicrobial agents Rugers, The State University of New Jersey (US) 2015-01-13 — — US disclosed
US-20130116278-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2013-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116278-A1 ANTIMICROBIAL AGENTS MRPL21, ARG1, RPP30 PTAFR 3790/4885FYN 3983/4885PAX8 4540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback